PCVX
Vaxcyte Inc
NASDAQ: PCVX · HEALTHCARE · BIOTECHNOLOGY
$57.32
-2.40% today
Updated 2026-04-29
Market cap
$8.28B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.63
Dividend yield
—
52W range
$28 – $65
Volume
1.3M
Vaxcyte Inc (PCVX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $39.63M | $70.80M | $65.70M | $392.83M | $324.34M | $1.01B | $1.41B | $3.51B |
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Current assets | $36.35M | $66.67M | $61.72M | $389.00M | $256.35M | $942.55M | $1.10B | $1.79B |
| Total liabilities | $8.69M | $128.53M | $172.07M | $46.98M | $40.32M | $52.56M | $167.45M | $205.50M |
| Current liabilities | $4.26M | $6.71M | $11.05M | $46.86M | $28.72M | $40.52M | $145.34M | $140.18M |
| Long-term debt | $3.76M | $3.65M | $450000.00 | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — |
| Retained earnings | $-29.59M | $-59.07M | $-109.35M | $-198.56M | $-298.64M | $-522.13M | $-924.39M | $-1.39B |
| Accounts receivable | — | — | $200000.00 | $300000.00 | $1.20M | $1.00M | $3.61M | $20.66M |
| Inventory | — | — | $-200000.00 | $-300000.00 | $-1.20M | $-1.00M | $-6.16M | — |
| Goodwill | — | — | — | — | — | — | — | — |